
2025-09
Targeted kutumira kwedhorobha Inotarisa pakuendesa maAratapeutic vamiririri zvakananga kumasokisi cancer, kuderedza kukuvadza kune hutano hwehutano. Iyi nzira inoshandisa nzira dzakasiyana-siyana, kusanganisira nuvariki, uye masero-penetirating eptides yekubudirira uye kuderedza zvinokanganisa, kupa cancer yakanyanya kurapa uye yakasarudzika cancer kurapwa.
Kurapwa kenza kwakashanduka zvakanyanya, ne Targeted kutumira kwedhorobha kubuda seyakajeka zano. Iyi nzira inovavarira kushandisa zvinosarudza zvinodhaka kune cancer masero, kuwedzera marongero ekurongedza paunenge uchidzora kukuvadza kune hutano matishu. Kusiyana nemakemiya akajairwa, ayo anogovera zvinodhaka mumuviri wese, anotariswa kuburitsa anoshandisa mashandiro akasiyana-siyana kune chaiyo chinangwa chekenza cancer cancer cancer cancer cancer cancer cancer cancer cancer cancer cancer cancer masero cancer.
Chomoterapy kazhinji inowanzoguma nemhedzisiro yakakosha nekuti inokanganisa masero ese ekumanikidza uye ane hutano. Targeted kutumira kwedhorobha inopa mhinduro nekuendesa zvinodhaka zvakananga kune bundu saiti. Izvi zvinoderedza hurongwa hwehurongwa, hunovandudza kushanda kwezvinodhaka, uye zvinogona kuwedzera hupenyu hwemurwere.
Nzira dzinoverengeka dzinoverengeka dzinoshandirwa mukati Targeted kutumira kwedhorobha, imwe neimwe nezviitwa zvayo uye zvaringana.
NAANOPArticles zvidiki zvidiki zvimedu (1-100 NM) zvakagadzirirwa kuti uwedzere uye kuendesa zvinodhaka kune cancer masero. Vanogona kuunganidzwa kuti vanongedze ma Receptors paCancer Cell, senge egfr kana yake2. Loschoms, polymeric naneoparticles, uye Isorganic naneparticles inoshandiswa. Iyo yekuvharirwa yekuvandudza uye kugarisana (EPR) mhedzisiro inobvumira Naneoparticcles kuti inyatsounganidza muTumor tishu nekuda kweBell Vasculature.
Muenzaniso: Doxil, liposomal Doxorubicin, inyanzvi inowanikwa yeNanopartic-yakavakirwa inoshandiswa kurapa cancer yeOvarian uye akawanda myeloma.
ADCS ine yeMonowl Anti Prody yakabatana neinodhaka cyttory. Iyo Antibody Inonyatsosungira kune anenge ataridzira antigen pamasero cancer, inotungamira kumukati yeADC uye inotevera kuburitswa kwemushonga mukati mechitokisi.
Muenzaniso: Adcetris (Brentuximab vedotin) Target
CPPs ipfupi amino Acino acid kutevedzera zvinoumba kupinda kwezvinodhaka kana nanharticles mumasero. Vanogona kuverengerwa kune varapi vamiririri kana nanoparticles kuti vasimudze cellular.
Iyi zano inosanganisira zvinorehwa anogamuchira anowana pane zvakawandisa pamasero cancer. Ligands kana antibodies anosunga kune vanobva vaiti vanoshandiswa kuendesa zvinodhaka kana nanharticles kuburikidza neEndocytosis.
Iyo Shandong Baoma cancer Research Institute Institute inoshanda mukutsvagisa nekukudziridza nokosi Targeted kutumira kwedhorobha masisitimu. Tsvagurudzo yavo inotarisa pane yakasarudzika nzira inofunga nezve yakasarudzika genetic uye molecular ma profiles yevarwere, chinangwa chekuvandudza kurapwa kwemhedzisiro uye kuderedza mhedzisiro.
Shandong baofa cancer Information Institute inoshanda nezvigaro zvevachipatara chipatara pabhasi chipatara (https ;bakosenpartal.com) Kuitisa miedzo yekiriniki uye kududzira zvidzidziso zvakawanikwa mune zvinoshanda zvinoshandiswa.
Targeted kutumira kwedhorobha inopa akati wandei zvakanakira pamusoro pechiitiko chemotherapy:
Pasinei nezvivimbiso zvacho, Targeted kutumira kwedhorobha Inotarisana nematambudziko akati wandei:
Dzinoverengeka Targeted kutumira kwedhorobha Systems parizvino inotenderwa kushandiswa kwekiriniki:
| Zita rezvinodhaka | Chinangwa | Cancer mhando | Nzira yekutumira |
|---|---|---|---|
| Doxil (liposomal doxorubicin) | Passive Targeting kuburikidza neEPR ACTER | Ovarian cancer, akawanda myeloma | Liposoms |
| Adcetris (Brentuximab vedotin) | CD30 | Hodgkin Lymphoma, Anaplastic yakakura cell Lymphoma | Antibody-zvinodhaka conjugate (Adc) |
| Kadyla (Trastuzumab Emtansine) | Her2 | Her2-yakanaka mazamu kenza | Antibody-zvinodhaka conjugate (Adc) |
Munda we Targeted kutumira kwedhorobha kukurumidza kubuda. Rwiyo rwembamangwana runotarisa:
Targeted kutumira kwedhorobha Inobata vimbiso yakakura kwazvo yekuvandudza cancer kurapwa uye zvabuda murwere. Sezvo tsvarakayeuka inoenderera, tinogona kutarisira kuona zvakanyanya kushanda uye kusarudzika Targeted kutumira kwedhorobha Maitiro anobuda, pakupedzisira anotungamira kune zvirinani cancer care.